Critical Issues 2012

final program

2012

May 24 & 25 lille

- france

course directors

StĂŠphan Haulon, lille, france Tim ResCh, malmĂś, sweden 6 credits

9 credits

steering committee for critical issues

Eric Verhoeven, Martin Malina, John Brennan & Richard McWilliams limited seats

16th

international experts symposium

Critical Issues in aortic endografting 2012

www.critical-issues-congress.com

facultY

Emmanuel ABATE, Buc, France

George HAMILTON, London, United Kingdom

Thierry REIX, Amiens, France

Donald ADAM, Birmingham, United Kingdom

Reda HASSEN-KHODJA, Nice, France

Martine REMY-JARDIN, Lille, France

Stéphan HAULON, Lille, France

Tim RESCH, Malmö, Sweden

Andrew Holden, Auckland, New Zealand

Vincent RIAMBAU, Barcelona, Spain

Krassi IVANCEV, London, United Kingdom

Blayne ROEDER, Bloomington, USA

Piergiorgio CAO, Rome, Italy

Michael JACOBS, Maastricht, The Netherlands

Uta Rosseck, Karlsruhe, Germany

Tom CARRELL, London, United Kingdom

Piotr KASPRZAK, Regensburg, Germany

Nick CHESHIRE, London, United Kingdom

Tilo KÖLBEL, Hamburg, Germany

Roberto CHIESA, Milan, Italy

Ralph KOLVENBACH,

Jean-Pierre BECQUEMIN, Créteil, France John BRENNAN, Liverpool, United Kingdom Peter BUNGAY, Derby, United Kingdom

Tim CHUTER, San Francisco, USA Rachel CLOUGH, London, United Kingdom Marc COGGIA, Boulogne, France Michael Dake, Stanford, USA Ghislaine Deklunder, Lille, France Jean-Paul DE VRIES, Nieuwegein, The Netherlands

Düsseldorf, Germany Mohamed Koussa, Lille, France Mario LACHAT, Zurich, Switzerland Anthony Lee, Bocaraton, USA Martin MALINA, Malmö, Sweden Blandine MAUREL, Lille, France Richard McWilliams, Liverpool, United Kingdom

Eric Ducasse, Bordeaux, France

Marco MIDULLA, Lille, France

Marcelo Ferreira, Rio de Janeiro, Brazil

Christoph NIENABER, Rostock, Germany

Martin FUNOVICS, Vienna, Austria

Michael Nilson, Flagstaff, USA

Marc Gianotti, Redwood City, USA

Alain Prat, Lille, France

Richard GIBBS London, United Kingdom

Giovanni PRATESI, Florence, Italy

Jonathan SOBOCINSKI, Lille, France Björn SONESSON, Malmö, Sweden Eric STEINMETZ, Dijon, France Peter TAYLOR, London, United Kingdom Jörg TESSAREK, Münster, Germany Matt THOMPSON, London, United Kingdom Frank VEITH, New York, USA Hence Verhagen, Rotterdam, The Netherlands Eric VERHOEVEN, Nuremberg, Germany Frank VERMASSEN, Gent, Belgium Fabio VERZINI, Perugia, Italy Willem WISSELINK, Amsterdam, The Netherlands

GE Healthcare

Complex procedures do not require complex solutions. You want a hybrid solution that brings high definition vascular imaging and flexibility in an environment you can be comfortable with. When you know the time is right to expand, advance and improve the care you give, trust a leader in vascular imaging technology.

Merging capabilities. Expanding opportunities.

The New Hybrid OR. Learn more at gehealthcare.com/euen/surgery/minimally_invasive_hybrid_OR.html

GE imagination at work Š 2012 General Electric Company.

More than

56,000 patients treated worldwide with Endurant in 3.5 years*

LOWERPROFILE,† HYDROPHILIC DELIVERY SYSTEM FOR ENHANCED ACCESS LONGER LIMB LENGTHS OFFER MULTIPLE OPTIONS TO IMPROVE EASE OF USE IMPROVED RADIOPACITY FOR INCREASED VISIBILITY TO AID IN GATE CANNULATION‡ **Patients treated with Endurant AAA Stent Graft System †28mm aortic stent graft ‡Gate cannulation marker

For more information, please visit medtronicendovascular.com

UC201201568EE © Medtronic, Inc. 2012. All Rights Reserved.

Thursday May 24 7.45 W elcoming coffee

8 .00 Thoracic Aorta Chairmen: S. Haulon, T. Chuter

part 1: acute type b dissections Late results from the INSTEAD trial, C. Nienaber Update on the ADSORB trial, E. Verhoeven Are aortic bare stents needed?, J. Sobocinski

Gore side branch endograft, M. Dake Predicting type B aortic dissection outcomes with computational flow analysis, R. Gibbs Dissection aortic devices, B. Roeder

P ANEL DEBATE: Do we need to change the current treatment guidelines in the treatment of acute uncomplicated type B dissection?

8 .50 part 2: unresolved thoracic aorta issues The celiac trunk should never be covered: current experience with the Bolton medical scalloped endograft, V. Riambau Endovascular treatment of mycotic thoracic aneurysms: bridge or definitive option?, P. Taylor Mixed evidence regarding coverage of the LSA, H. Verhagen Retrograde ascending hematoma, M. Dake P ANEL DEBATE

9 .30 i maging

Chairmen: T. Resch, R. McWilliams New CT protocols to lower radiation dose and contrast media volume before and after aortic endografting, M. Remy-Jardin Fusion imaging: development of a new software, T. Carrell

Evaluation of new endografts: can MRI predict failure?, R. Clough

Mobile or fixed imaging systems to perform aortic endografting?, S. Haulon

Fusion imaging, 3D rotational angiography or CO2 for standard and complex aortic endografting, K. Ivancev

EVAR follow-up with Ultra-Sound, G. Deklunder

P ANEL DEBATE: Should we modify the current EVAR follow-up recommendations?

10.30 B reak on the exhibition hall

Thursday May 24

1 1.00 P ara renal aneurysms, Patients selection

Chairmen: G. Hamilton, P. Cao Which patients should not have para renal aneurysms open repair?, E. Steinmetz Which patients should not have para renal aneurysms laparoscopic repair?, M. Coggia When can chimneys work?, M. Malina Fenestrated endografts: causes of long term failure, J. Brennan Can the Endologix Nellix repair all para renal aneurysms?, A. Holden Results from the French multicentric fenestrated trial: can we predict outcomes?, J-P. Becquemin

P ANEL DEBATE: Which treatment for which patient?

1 2.00 P ara renal aneurysms, technical aspects Chairmen: P. Taylor, M. Ferreira Secondary procedures after aortic aneurysm repair with fenestrated and branched endografts, J. Tessarek Vascutek fenestrated endograft: current indications and limitations, P. Bungay Endologix Ventana off-the-shelf fenestrated endograft: current indications and limitations, A. Holden Cook medical off-the-shelf fenestrated endograft: current indications and limitations, T. Resch Medtronic abdominal branched endograft: current indications and limitations, W. Wisselink P ANEL DEBATE: Which endograft for which anatomy?

13.00 L unch on the exhibition hall

1 4.00 Thoracoabdominal Aneurysms part 1 Chairmen: E. Verhoeven, F. Veith Open or endovascular repair?, P. Cao Hybrid repair of thoracoabdominal aortic aneurysms: state of the art, R. Chiesa Methods of preventing spinal cord ischaemia during TAA open and endovascular surgery, J-P. de Vries Update on the “sac perfusion branch� to prevent spinal cord ischaemia, K. Ivancev Endovascular repair: how to minimize post operative risk, T. Resch P ANEL DEBATE: Should only high volume centers perform these procedures?

1 4.45 Thoracoabdominal Aneurysms part 2

Chairmen: M. Jacobs, B. Sonesson Pre loaded branched and fenestrated endografts, P. Kasprzak The configuration of sidebranches is important to match anatomy, M. Ferreira “Off the shelf” branched endograft: patient selection and sizing, T. Chuter Repair of recurrent visceral aortic patch aneurysm after open thoracoabdominal aortic aneurysm repair, D. Adam Chronic type B dissections: are fenestrated and branched endografts an option?, S. Haulon P ANEL DEBATE: What are the current contra indications for TAAA endovascular repair?

15.30 B reak on the exhibition hall

1 6.00 N ew technologies - New Aortic Endografts and Bridging stents Chairmen: V. Riambau, K. Ivancev Robotic endovascular catheters for arch vessel cannulation, N. Cheshire New generation Atrium medical stentgraft, E. Verhoeven Cordis abdominal endograft, G. Pratesi Cook medical purpose build bridging stents, B. Roeder Medtronic next generation abdominal endograft, P. Cao Dissection cutting catheter, M. Nilson New ABBOTT VASCULAR stentgraft projects, M. Gianotti The new generation BARD stent graft for SFA disease, U. Rosseck Clinical trial results of Treovance, the latest generation of AAA stentgraft, R. Chiesa P ANEL DEBATE: “New” is “better”? Assessment of durability and clinical utility?

17.30

he next generation of Hybrid OR systems T from GE Healthcare, E. Abate

18.00 GE cocktail 20.30 O fficial dinner

on the exhibition hall

friday May 25 8.00 W elcoming coffee

8 .15 Abdominal Aorta

Chairmen: M. Malina, T. Reix Does EVAR suitability impact outcomes of AAA and rAAA repair, F. Veith Improved results with 3rd generation endografts, F. Verzini Percutaneous closure devices: technique and literature review, R. Hassen-Khodja Endovascular repair of aorto-enteric fistula: a bridge to surgery?, F. Vermassen Endovascular repair of aortic aneurysms under local anaesthesia, M. Lachat Aortic bifurcation occlusive disease: are covered stents an alternative?, P. Kasprzak

P ANEL DEBATE

9 .20 Internal Iliac Branch

Chairmen: A. Holden, E. Ducasse Internal iliac occlusion is safe during EVAR, F. Veith

Internal iliac occlusion is unnecessary during EVAR, E. Verhoeven Tips and tricks for branched iliac, G. Pratesi

Preliminary experience with the bifurcated iliac device, B. Roeder PANEL DEBATE: Is buttock claudication an issue?

10.00 B reak on the exhibition hall

1 0.30 Arch

Chairmen: M. Koussa, S. Haulon Medtronic branched endograft, M. Thompson Open and hybrid techniques, B. Maurel bolton medical branched endograft, A. Lee In-situ fenestrations, B. Sonesson COOK medical branched endograft, T. Chuter PANEL DEBATE: Which technique for which patient?

1 1.30 Ascending Aorta

Chairmen: M. Thompson, A. Prat What is the best method for precise endograft implantation: rapid pacing, IVC occlusion, drugs?, C. Nienaber Type A dissections: anatomical studies, J. Sobocinski Ascending aorta endografting, R. Kolvenbach Visceral fenestration prior to ascending aorta open repair in acute type A dissections, M. Midulla Transseptal and transapical antegrade access for TEVAR, T. Kรถlbel Ascending aorta endografting: the Bolton Medical experience, M. Funovics

P ANEL DEBATE: Is it time for prospective randomized trial versus open repair?

12.30 A djournment

www.critical-issues-congress.com

Congress venue World Trade Center / Crowne Plaza Lille - Euralille 335 Bd de Leeds - Lille, 59777 - France Tel. +33 (0)3 20 42 46 46 - Fax. +33 (0)3 20 40 13 14 www.lille-crowneplaza.com Facing the TGV train station, very close to the old city of Lille.

Train station: TGV / Eurostar: Lille Europe or Lille Flandres Airport: Lille – Lesquin (10km) Road: A1 highway. Follow «Lille centre», exit «Gare Lille Europe» Hotel day parking card: 20e (reservation mandatory)

Registration fees

before march

12

after & onsite

Physicians or exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . 370€ . . . . . . . . . . . . . 470€ Residents, fellows, nurses & technicians . . . . . . . . . . 200€ . . . . . . . . . . . . . 250€ (a confirmation letter will be asked)

The registration fees include: access to all Scientific Medical Sessions, access to exhibition Hall, welcoming coffees, coffee breaks & the lunch only on Thursday May 24.

Hotel accommodation including breakfast, city tax not included

➊ Congress venue: Crowne Plaza Lille**** 335 Bd de Leeds ➋ Carlton Lille Hotel**** . . . . . . . . . . . . . . . . . . .

3, rue de Paris (15 mn walk) ➌ Hôtel Up**** . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17 place des Reignaux (10 mn walk) ➍ Lille Europe Hotel** . . . . . . . . . . . . . . . . . . . . . .

Av. le Corbusier (6 mn walk)

single

double

fully booked 175,00€ 200,00€ . fully . . . . . . . . 200,00€ booked 199,00€ . fully . . . . . . . . 228,00€ booked

175,00€

. . . . . . . . .

107,50€

. . . . . . . . .

116,00€

Cancellation before April 20: refund less 10% (administrative charge). Cancellation after April 20: no refund will be given. Name changes will be accepted before May 11. No-Shows at the congress will be charged the full fee. Refund will be processed until end of September 2012.

One night deposit needed to confirm any hotel booking. The whole stay has to be paid before April 20 to avoid cancellation of reservation. City tax is not included.

Register online at www.critical-issues-congress.com

la

on

lge Be

M

To ur s

de

na

ie

Ru ed es

e

ple eu uP .d Av

Ru

cques

ROUBAIX TOURCOING

int-Ja eSa

Ru

Notre Dame de la Treille

Bd Car not

ers

Thi

ers

.l Av

Place de l’Europe

D14

rg ou mb ur xe ste Lu Pa de u is Lo in Bd Tur de Bd

ier

us

rb

o eC

e Ru

i onn Can

Opéra de Lille

Gare de Lille-Europe

Parc Henri Matisse

des

Rue

se Bas

Rue

VIEUX LILLE

Rue

Bd

Jacq

uet

Parc des Dondaines

ris Pa

r eu ast is P

de

e

Ru

Gare de Lille-Flandres

u Lo

e Ru

ale

on

ène

Gare de Lille-Flandres

Grand Place

ti Na

Eug

L’Aéronef

Rihour Office de Tourisme et des Congrès de Lille

Ru

ed

eT ou

rn

ai

Rue

Jav a

l

ne

Bd

de

u

ed

Ru

er

41 D651

isson

Dubu

Square Augustin Laurent

Aéroport de Lille-Lesquin

mile

Musée des Beaux-Arts de Lille

ris

Rue de Pa

té

ublique des ux-Arts

Mairie de Lille

edy

n Ken

ry

D9

Lib

ent

résid

uP Av. d

Bd E

la

li Mo

A1 / PARIS A16 / VALENCIENNES A25 / DUNKERQUE A26 / REIMS A27 / BRUXELLES

Official dinner Thursday May 24 (20.30) ➎ “Au bout des doigts” restaurant Registration mandatory at the registration desk Contribution to costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20€ per person

R E L AY T h o ra c i c S t e n t-G ra f t Worldwide experience of 5000 patients reached

Bolton Medical envisions to become a reference in the endovascular treatment of the entire aorta

2012

TREOVANCE TREOVANCE Abdominal Abdominal Stent-Graft Stent-Graft CE Mark ADVANCE CE RELAY NBS Mark Approval Branched PLUS Thoracic Study completion Stent-Graft Stent-Graft CE project Mark Approval development

2011

RELAY Thoracic Stent-Graft First-in Human FDA Phase II RELAY Branched Trial Completion Thoracic Stent-Graft

RELAY Thoracic Stent-Graft 250 mm length lowest number of stent-graft Bolton RELAY per patient Medical Thoracic Custom Made within TEVAR Stent-Graft Program CE Mark

2005

2006 RELAY Thoracic Stent-Graft FDA Phase I Trial Completion

2007

2010

RELAY PLUS Thoracic Stent-Graft CE 5000 patients Mark Approval treated with 3000 Patients the RELAY treated with the Thoracic StentRELAY Thoracic Graft Brand Stent-Graft Brand 2000 Patients treated with the RELAY Thoracic RELAY NBS Stent-Graft Brand Thoracic

2009

2008

Stent-Graft CE Mark

RELAY NBS Thoracic Stent-Graft Halfway point in the U.S. Phase II clinical trial

Manufacturer: Bolton Medical España, S.L.U. c\ Newton 18-24, 08635 – Sant Esteve Sesrovires, Barcelona, Spain +34.93.813.63.23 U.S. Headquarters. Bolton Medical Inc. 799 International Parkway, Sunrise, FL 33325, +1.954.838.9699 RELAY PLUS - Caution: Investigational device. Limited by U.S. law to investigational use. RELAY NBS PLUS: Not for sale in the U.S.

Acknowledgments

ORGANIZATION: divine [id] agency Vérane Bergeron Moreau & Christine Arzouyan Tél. +33 (0) 491 57 19 60 Fax +33 (0) 491 57 19 61 carzouyan@divine-id.com www.divine-id.com

critical issues 2012 - lille - france

2012

May 24 & 25 lille

- france

www.critical-issues-congress.com